mesylate

Known as: mesilate, methane sulfonate, methanesulfonate 
 

Topic mentions per year

Topic mentions per year

1967-2017
0204019672017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Anti-PARP drugs were initially developed as catalytic inhibitors to block the repair of DNA single-strand breaks. We recently… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Telomeres protect chromosome ends from fusion and degradation. In the absence of a specific telomere elongation mechanism, their… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE To assess potential differences in progression-free or overall survival when imatinib mesylate is administered to… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
PURPOSE Imatinib mesylate is standard treatment for patients who have advanced gastrointestinal stromal tumor (GIST), but not all… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2008
2008
OBJECTIVE To examine the effectiveness of imatinib mesylate in the treatment of nephrogenic systemic fibrosis (NSF). METHODS… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The BCR-ABL kinase inhibitor imatinib mesylate induces complete cytogenetic response (CCR) in a high proportion of chronic… (More)
  • figure 1
  • table 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Imatinib mesylate, an inhibitor of the Bcr-Abl tyrosine kinase, has modest activity in refractory/relapsed Philadelphia… (More)
  • table 1
  • table 2
  • table 2
  • table 2
  • figure 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
Imatinib mesylate (Glivec, formerly STI571) is the first effective systemic treatment for gastrointestinal stromal tumours (GISTs… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Twenty-eight adults with chronic myelogenous leukemia (CML) that had relapsed after allogeneic stem cell transplantation (SCT… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The Saccharomyces cerevisiae RAD9 checkpoint gene is required for transient cell-cycle arrests and transcriptional induction of… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?